9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma

Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma

Estimated reading time: < 1 min

Condition: Recurrent Malignant Mesothelioma

Estimated Enrollment: 15

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Active, not recruiting

Study Results: No Results Available

Outcome Measures: Adverse event (AE) profile,  Describe the safety of the intrapleural administration of MV-NIS in patients with malignant pleural mesothelioma for all cycles out to 90 days.,  ,

Interventions: oncolytic measles virus encoding thyroidal sodium iodide symporter, laboratory biomarker analysis

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Treatment,

Primary Completion Date: December 2019

Completion Date: December 2019

Last  Posted Date: March 4, 2019

Location: Mayo Clinic, Rochester, Minnesota, United States

Website Link: https://ClinicalTrials.gov/show/NCT01503177

Was this article helpful?
Dislike 0